Search Results - "Voulgarelis, M."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) by Voulgarelis, M, Giannouli, S, Tzioufas, A G, Moutsopoulos, H M

    Published in Annals of the rheumatic diseases (01-08-2006)
    “…Background: Primary Sjögren’s syndrome (SS) is associated with an increased frequency of non-Hodgkin’s lymphomas (NHLs), mainly of low histological grade…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment by Giannouli, S, Voulgarelis, M, Ziakas, P D, Tzioufas, A G

    Published in Annals of the rheumatic diseases (01-02-2006)
    “…Haematological abnormalities are common in systemic lupus erythematosus. Anaemia is found in about 50% of patients, with anaemia of chronic disease being the…”
    Get full text
    Journal Article Book Review
  7. 7

    Monomorphic epitheliotropic intestinal T‐cell lymphoma in pleural effusion: A case report by Antoniadou, F., Dimitrakopoulou, A., Voutsinas, P. M., Vrettou, K., Vlahadami, I., Voulgarelis, M., Korkolopoulou, P., Kafasi, N., Mikou, P.

    Published in Diagnostic cytopathology (01-11-2017)
    “…Dissemination of lymphomas in serous effusions is quite common. Cytology aims to contribute in the clinical management of haematologic patients, providing an…”
    Get full text
    Journal Article
  8. 8

    Exacerbation of interstitial granulomatous dermatitis with arthritis by anakinra in a patient with diffuse large B-cell lymphoma by Michailidou, D, Voulgarelis, M, Pikazis, D

    Published in Clinical and experimental rheumatology (01-03-2014)
    “…Interstitial granulomatous dermatitis with arthritis (IGDA) is a rare idiopathic skin disorder with variable cutaneous expression, typically associated with a…”
    Get full text
    Journal Article
  9. 9

    Mortality in Sjögren's syndrome by Voulgarelis, M, Tzioufas, A G, Moutsopoulos, H M

    Published in Clinical and experimental rheumatology (01-09-2008)
    “…Sjögren's syndrome (SS) is a chronic autoimmune disease that involves primarily the exocrine glands and results in their functional impairment. The disease may…”
    Get full text
    Journal Article
  10. 10

    Stress, coping strategies and social support in patients with primary Sjögren's syndrome prior to disease onset: a retrospective case-control study by Karaiskos, D, Mavragani, C P, Makaroni, S, Zinzaras, E, Voulgarelis, M, Rabavilas, A, Moutsopoulos, H M

    Published in Annals of the rheumatic diseases (01-01-2009)
    “…Previous evidence suggests the role of psychological stress in triggering the onset of autoimmunity. We aimed to investigate whether stress following major and…”
    Get more information
    Journal Article
  11. 11

    Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts by Voulgarelis, M., Giannouli, S., Ritis, K., Tzioufas, A. G.

    Published in European journal of clinical investigation (01-10-2004)
    “…Myelodysplastic syndrome (MDS), an acquired clonal disorder of haemopoietic progenitor cells, is characterized by haemopoietic insufficiency associated with…”
    Get full text
    Journal Article
  12. 12

    Lupus thrombocytopenia: clinical implications and prognostic significance by Ziakas, P D, Giannouli, S, Zintzaras, E, Tzioufas, A G, Voulgarelis, M

    Published in Annals of the rheumatic diseases (01-09-2005)
    “…Objectives: To clarify clinical manifestations, association with disease activity, and prognostic impact of thrombocytopenia using simple and reliable indices…”
    Get full text
    Journal Article
  13. 13

    Absence of somatic MYD88 L265P mutations in patients with primary Sjogren’s syndrome by Voulgarelis, M, Mavragani, C P, Xu, L, Treon, S P, Moutsopoulos, H M

    Published in Genes and immunity (01-01-2014)
    “…Sjogren’s syndrome (SS) is a chronic autoimmune disorder with the highest risk for lymphoma development among all autoimmune diseases. In order to evaluate…”
    Get full text
    Journal Article
  14. 14

    Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas by VOULGARELIS, M, GIANNOULI, S, ANAGNOSTOU, D, TZIOUFAS, A. G

    Published in Rheumatology (Oxford, England) (01-08-2004)
    “…To determine the safety and therapeutic response of a regimen consisting of cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) plus rituximab in…”
    Get full text
    Journal Article
  15. 15

    Suspects in the tale of lupus‐associated thrombocytopenia by Ziakas, P. D., Routsias, J. G., Giannouli, S., Tasidou, A., Tzioufas, A. G., Voulgarelis, M.

    Published in Clinical and experimental immunology (01-07-2006)
    “…Summary Immunologically mediated thrombocytopenia is a frequent clinical manifestation in patients with systemic lupus erythematosus (SLE). Autoantibodies…”
    Get full text
    Journal Article
  16. 16

    Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: A clinicopathological study by Voulgarelis, M., Giannouli, S., Tasidou, A., Anagnostou, D., Ziakas, P.D., Tzioufas, A.G.

    Published in American journal of hematology (01-08-2006)
    “…Background: The histopathologic features characterizing the involvement of the bone marrow (BM) in systemic lupus erythematosus (SLE) have not been…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Malignant lymphoma in primary Sjögren’s syndrome: An update on the pathogenesis and treatment by Routsias, John G., MD, PhD, Goules, John D., BS, Charalampakis, Georgios, DMD, Tzima, Sotiria, PhD, Papageorgiou, Aristea, MD, Voulgarelis, Michael, MD, PhD

    Published in Seminars in arthritis and rheumatism (01-10-2013)
    “…Abstract Objectives Sjögren’s syndrome (SS), a chronic autoimmune disorder, particularly compromises the function of exocrine glands. Its association with…”
    Get full text
    Journal Article
  19. 19

    Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression by Giannouli, S, Tzoanopoulos, D, Ritis, K, Kartalis, G, Moutsopoulos, H M, Voulgarelis, M

    Published in Annals of the rheumatic diseases (01-05-2004)
    “…Background: Patients with myelodysplasia may have autoimmune manifestations (AIM). Interferon regulatory factor-1 (IRF-1) is a transcription factor involved in…”
    Get full text
    Journal Article
  20. 20

    Thrombocytopaenia in lupus as a marker of adverse outcome : seeking Ariadne's thread by ZIAKAS, P. D, DAFNI, U. G, GIANNOULI, S, TZIOUFAS, A. G, VOULGARELIS, M

    Published in Rheumatology (Oxford, England) (01-10-2006)
    “…To assess the role of thrombocytopaenia as an independent predictor of outcome in patients with systemic lupus erythematosus (SLE). This was a single-centre,…”
    Get full text
    Journal Article